Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Glenmark Pharmaceuticals Limited Press Release Jul 17 2024

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Filed with NSE ·

On 6ix: 6ix.com/news/glenmark-pharmaceuticals-limited-press-release-jul-17-2024

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 17, 2024, titled "Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases